NasdaqGM - Delayed Quote • USD
Biodesix, Inc. (BDSX)
At close: May 28 at 4:00 PM EDT
After hours: May 28 at 4:00 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 4 | 4 |
| Avg. Estimate | -0.09 | -0.07 | -0.36 | -0.26 |
| Low Estimate | -0.1 | -0.08 | -0.38 | -0.32 |
| High Estimate | -0.09 | -0.07 | -0.34 | -0.22 |
| Year Ago EPS | -0.17 | -0.14 | -0.64 | -0.36 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 4 | 4 |
| Avg. Estimate | 16.22M | 17.39M | 66.77M | 82.78M |
| Low Estimate | 15.67M | 16.85M | 65.5M | 81.43M |
| High Estimate | 17M | 18M | 68.6M | 83.4M |
| Year Ago Sales | 11.87M | 13.49M | 49.09M | 66.77M |
| Sales Growth (year/est) | 36.60% | 28.90% | 36.00% | 24.00% |
Earnings History
| CURRENCY IN USD | 6/30/2023 | 9/30/2023 | 12/31/2023 | 3/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.21 | -0.15 | -0.11 | -0.14 |
| EPS Actual | -0.17 | -0.14 | -0.1 | -0.14 |
| Difference | 0.04 | 0.01 | 0.01 | 0 |
| Surprise % | 19.00% | 6.70% | 9.10% | 0.00% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.09 | -0.07 | -0.36 | -0.26 |
| 7 Days Ago | -0.09 | -0.08 | -0.36 | -0.26 |
| 30 Days Ago | -0.09 | -0.08 | -0.4 | -0.3 |
| 60 Days Ago | -0.1 | -0.09 | -0.42 | -0.32 |
| 90 Days Ago | -0.12 | -0.12 | -0.49 | -0.31 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | 1 | 1 |
| Up Last 30 Days | 1 | 1 | 1 | 2 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | BDSX | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 47.10% | -- | -- | 7.90% |
| Next Qtr. | 50.00% | -- | -- | 10.20% |
| Current Year | 43.80% | -- | -- | 4.80% |
| Next Year | 27.80% | -- | -- | 12.50% |
| Next 5 Years (per annum) | -- | -- | -- | 11.27% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Initiated | TD Cowen: Buy | 5/13/2024 |
| Initiated | Lake Street: Buy | 5/3/2024 |
| Reiterates | Canaccord Genuity: Buy to Buy | 3/4/2024 |
| Reiterates | Canaccord Genuity: Buy to Buy | 12/7/2023 |
| Maintains | Morgan Stanley: Equal-Weight | 5/12/2022 |
| Initiated | Cowen & Co.: Outperform | 4/20/2022 |
Related Tickers
IDXG Interpace Biosciences, Inc.
1.5500
+4.73%
MYGN Myriad Genetics, Inc.
23.32
+0.69%
PSNL Personalis, Inc.
1.2900
-3.73%
STIM Neuronetics, Inc.
2.0800
-4.59%
CSTL Castle Biosciences, Inc.
24.53
+0.66%
RSHN RushNet, Inc.
0.0003
+20.00%
SKHCF Sonic Healthcare Limited
16.15
-3.61%
CNTG Centogene N.V.
0.3898
+4.22%
AWH Aspira Women's Health Inc.
2.2200
-3.90%
SZLS.TO StageZero Life Sciences Ltd.
0.0400
0.00%